Abstract

The identification and prognosis of the potential for developing Cardiovascular
Diseases (CVD) in healthy individuals is a vital aspect of disease management. Accessing the comprehensive health data on CVD currently available within hospital databases holds significant potential for the early detection and diagnosis of CVD, thereby positively impacting disease outcomes. Therefore, the incorporation of machine learning methods holds significant promise in the advancement of clinical practice for the management of Cardiovascular Diseases (CVDs). By providing a means to develop evidence-based clinical guidelines and management algorithms, these techniques can eliminate the need for costly and extensive clinical and laboratory investigations, reducing the associated financial burden on patients and the healthcare system. In order to optimize early prediction and intervention for CVDs, this study proposes the development of novel, robust, effective, and efficient machine learning algorithms, specifically designed for the automatic selection of key features and the detection of early-stage heart disease. The proposed Catboost model yields an F1-score of about 92.3% and an average accuracy of 90.94%. Therefore, compared to many other existing state-of-art approaches, it successfully achieved and maximized classification performance with higher percentages of accuracy and precision.

Description

This study proposes the development of machine learning algorithms, specifically designed for the automatic selection of key features and the detection of early-stage heart disease. The proposed Catboost model yields an F1-score of about 92.3% and an average accuracy of 90.94%. Therefore, Compared to many other existing state-of-art approaches, it successfully achieved and maximized classification performance with higher percentages of accuracy and precision.

Author Details

Nadiah Abdulaziz Baghdadi, PhD; Sally Mohammed Farghaly Abdelaliem, PhD; Amer Malki, PhD; Ibrahim Gad, PhD; Ashraf Ewis, PhD; Elsayed Atlam, PhD

Sigma Membership

Alpha Beta Tau at-Large

Type

Presentation

Format Type

Text-based Document

Study Design/Type

Other

Research Approach

Translational Research/Evidence-based Practice

Keywords:

Acute Care, Heart Disease, Machine Learning, Feature Selection, Cardiovascular Diseases, Quality of Life, Disease Prevention, CVD

Conference Name

36th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Seattle, Washington, USA

Conference Year

2025

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

Review Type

Abstract Review Only: Reviewed by Event Host

Acquisition

Proxy-submission

Click on the above link to access the slide deck.

Additional Files

References.pdf (127 kB)

Share

COinS
 

Advanced Machine Learning Techniques for Cardiovascular Disease: Early Detection and Diagnosis

Seattle, Washington, USA

The identification and prognosis of the potential for developing Cardiovascular
Diseases (CVD) in healthy individuals is a vital aspect of disease management. Accessing the comprehensive health data on CVD currently available within hospital databases holds significant potential for the early detection and diagnosis of CVD, thereby positively impacting disease outcomes. Therefore, the incorporation of machine learning methods holds significant promise in the advancement of clinical practice for the management of Cardiovascular Diseases (CVDs). By providing a means to develop evidence-based clinical guidelines and management algorithms, these techniques can eliminate the need for costly and extensive clinical and laboratory investigations, reducing the associated financial burden on patients and the healthcare system. In order to optimize early prediction and intervention for CVDs, this study proposes the development of novel, robust, effective, and efficient machine learning algorithms, specifically designed for the automatic selection of key features and the detection of early-stage heart disease. The proposed Catboost model yields an F1-score of about 92.3% and an average accuracy of 90.94%. Therefore, compared to many other existing state-of-art approaches, it successfully achieved and maximized classification performance with higher percentages of accuracy and precision.